This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Pathogenesis

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Microbial infection and dysfunctional immunity contribute to the pathophysiology of bronchiectasis (1).

Essential components of bronchiectasis include impaired mucociliary clearance and structural changes in the walls of the bronchi.

  • The structural changes may be a consequence of impaired mucociliary clearance defects in ciliary motility, or, occur together

Acute severe lower respiratory infection, chronic low grade respiratory infection in an immunodeficient patient.

The majority of adult cases at present are due to severe respiratory childhood infection, such as measles or whooping cough.

  • Bronchial obstruction may lead to bronchiectasis in the lung distal to the block e.g. due to tuberculous lymph nodes, carcinoma, foreign body.
  • Proximal bronchiectasis may be seen in allergic aspergillosis.
  • Bronchiectasis may also accompany congenitally atelectic lobes and ciliary dyskinesia.

Reference:

  1. Chalmers JD, Chang AB, Chotirmall SH, Dhar R, McShane PJ. Bronchiectasis. Nat Rev Dis Primers. 2018 Nov 15;4(1):45. doi: 10.1038/s41572-018-0042-3.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.